Fertility Drug and Surgery Market Research Report, by Underlying Cause (Male and Female), Drugs (Clomiphene Citrate, Letrozole), Procedures (Hysteroscopy, Laparoscopy, Robotic Laparoscopy), and End User (Fertility Clinics) — Global Forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Fertility Drug and Surgery Market, by Underlying Cause

6.1 Overview

6.2 Male

6.3 Female

Chapter 7. Global Fertility Drug and Surgery Market, by Drugs

7.1 Overview

7.2 Clomiphene Citrate

7.3 Letrozole

7.4 Serophene

7.5 Hormone Treatment

7.6 Gonadotrophins

7.7 Aromatase Inhibitors

7.8 Estrogen Receptor Modulators

7.9 Dopamine Agonists

7.10 Metformin Hydrochloride

7.11 Others

Chapter 8. Global Fertility Drug and Surgery Market, by Procedures

8.1 Overview

8.2 Hysteroscopy

8.3 Laparoscopy and Robotic Laparoscopy

8.4 Laparotomy/Open Surgery

8.5 Egg Retrieval

8.6 Varicocelectomy

8.7 Vasectomy Reversal

8.8 Sperm Retrieval

Chapter 9. Global Fertility Drug and Surgery Market, by End Users

9.1 Overview

9.2 Fertility Clinics

9.3 Hospitals

9.4 Clinical Research Institutes

9.5 Others

Chapter 10. Global Fertility Drug and Surgery Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

Chapter 12. Company Profiles

12.1 Eli Lilly

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Baxter Healthcare Corporation

12.3 Ferring Pharmaceuticals, Inc.

12.4 Merck & Co. Pharmaceutical Company

12.5 Noven Pharmaceuticalorganon, Inc.

12.6 Janssen Pharmaceuticals Inc.

12.7 Personal Products Company

12.8 Pfizer, Inc.

12.9 Procter & Gamble Pharmaceuticals

12.10 Emd Serono, Inc.

12.11 Others

Chapter 13 Appendix

LIST OF TABLES

TABLE 1 GLOBAL FERTILITY DRUG AND SURGERY MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL FERTILITY DRUG AND SURGERY MARKET ESTIMATES AND FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 6 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 7 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027(USD MILLION)

TABLE 8 NORTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 10 NORTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 11 NORTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 12 NORTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 13 US: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 14 US: FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 15 US: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 16 US: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 17 US: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 18 CANADA: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 19 CANADA: FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 20 CANADA: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 21 CANADA: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 22 CANADA: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 23 SOUTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 24 SOUTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 25 SOUTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 26 SOUTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 27 SOUTH AMERICA: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 28 EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 29 EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 30 EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 31 EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 32 EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 33 WESTERN EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 34 WESTERN EUROPE FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 35 WESTERN EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 36 WESTERN EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 37 WESTERN EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 38 EASTERN EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 39 EASTERN EUROPE FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 40 EASTERN EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 41 EASTERN EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 42 EASTERN EUROPE: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 43 ASIA-PACIFIC: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 44 ASIA-PACIFIC FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 45 ASIA-PACIFIC: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 46 ASIA-PACIFIC: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 47 ASIA-PACIFIC: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA: FERTILITY DRUG AND SURGERY MARKET, BY UNDERLYING CAUSE, 2020–2027 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020–2027 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA: FERTILITY DRUG AND SURGERY MARKET, BY PROCEDURES, 2020–2027 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA: FERTILITY DRUG AND SURGERY MARKET, BY END USERS, 2020–2027 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA: FERTILITY DRUG AND SURGERY MARKET, BY REGION, 2020–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 SEGMENTATION FOR GLOBAL FERTILITY DRUG AND SURGERY MARKET

FIGURE 3 MARKET DYNAMICS FOR GLOBAL FERTILITY DRUG AND SURGERY MARKET

FIGURE 4 GLOBAL FERTILITY DRUG AND SURGERY MARKET SHARE, BY UNDERLYING CAUSE, 2020 (%)

FIGURE 5 GLOBAL FERTILITY DRUG AND SURGERY MARKET, BY DRUGS, 2020 (%)

FIGURE 6 GLOBAL FERTILITY DRUG AND SURGERY MARKET SHARE, BY PROCEDURES, 2020 (%)

FIGURE 7 GLOBAL FERTILITY DRUG AND SURGERY MARKET SHARE, BY END USERS, 2020 (%)

FIGURE 8 GLOBAL FERTILITY DRUG AND SURGERY MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: FERTILITY DRUG AND SURGERY MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: FERTILITY DRUG AND SURGERY MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 ASIA-PACIFIC: FERTILITY DRUG AND SURGERY MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 MIDDLE EAST & AFRICA: FERTILITY DRUG AND SURGERY MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 GLOBAL FERTILITY DRUG AND SURGERY MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 14 NOVARTIS AG: KEY FINANCIALS

FIGURE 15 NOVARTIS AG: SEGMENTAL REVENUE

FIGURE 16 NOVARTIS AG: GEOGRAPHICAL REVENUE

FIGURE 17 BAXTER HEALTHCARE CORPORATION: KEY FINANCIALS

FIGURE 18 BAXTER HEALTHCARE CORPORATION: SEGMENTAL REVENUE

FIGURE 19 BAXTER HEALTHCARE CORPORATION: GEOGRAPHICAL REVENUE

FIGURE 20 FERRING PHARMACEUTICALS, INC.: KEY FINANCIALS

FIGURE 21 FERRING PHARMACEUTICALS, INC.: SEGMENTAL REVENUE

FIGURE 22 FERRING PHARMACEUTICALS, INC.: GEOGRAPHICAL REVENUE

FIGURE 23 MERCK & CO. PHARMACEUTICAL COMPANY: KEY FINANCIALS

FIGURE 24 MERCK & CO. PHARMACEUTICAL COMPANY: SEGMENTAL REVENUE

FIGURE 25 MERCK & CO. PHARMACEUTICAL COMPANY: GEOGRAPHICAL REVENUE

FIGURE 26 NOVEN PHARMACEUTICALORGANON, INC.: KEY FINANCIALS

FIGURE 27 NOVEN PHARMACEUTICALORGANON, INC.: SEGMENTAL REVENUE

FIGURE 28 NOVEN PHARMACEUTICALORGANON, INC.: GEOGRAPHICAL REVENUE

FIGURE 29 JANSSEN PHARMACEUTICALS INC.: KEY FINANCIALS

FIGURE 30 JANSSEN PHARMACEUTICALS INC.: SEGMENTAL REVENUE

FIGURE 31 JANSSEN PHARMACEUTICALS INC.: GEOGRAPHICAL REVENUE

FIGURE 32 PERSONAL PRODUCTS COMPANY: KEY FINANCIALS

FIGURE 33 PERSONAL PRODUCTS COMPANY: SEGMENTAL REVENUE

FIGURE 34 PERSONAL PRODUCTS COMPANY: GEOGRAPHICAL REVENUE

FIGURE 35 PFIZER, INC.: KEY FINANCIALS

FIGURE 36 PFIZER, INC.: SEGMENTAL REVENUE

FIGURE 37 PFIZER, INC.: GEOGRAPHICAL REVENUE

FIGURE 38 PROCTER & GAMBLE PHARMACEUTICALS: KEY FINANCIALS

FIGURE 39 PROCTER & GAMBLE PHARMACEUTICALS: SEGMENTAL REVENUE

FIGURE 40 PROCTER & GAMBLE PHARMACEUTICALS: GEOGRAPHICAL REVENUE

FIGURE 41 EMD SERONO, INC.: KEY FINANCIALS

FIGURE 42 EMD SERONO, INC.: SEGMENTAL REVENUE

FIGURE 43 EMD SERONO, INC.: GEOGRAPHICAL REVENUE